A real world study analysing evidence of 18F-Fluciclovine Pet/Ct utilization for recurrent Prostate Cancer
Latest Information Update: 08 Dec 2021
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 30 Nov 2021 According to a Blue Earth Diagnostics media release, data from this trial will be presented at the upcoming 22nd Annual Scientific Meeting in Urologic Oncology (SUO).
- 28 Oct 2021 New trial record
- 13 Sep 2021 Primary endpoint has been met. (result of 18F-fluciclovine PET/CT), as per Results presented at the 116th Annual Meeting of the American Urological Association